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Objective: To assess the value of the new differential culture medium CHROMagar Candida for routine investigation 
of clinical specimens. 
Methods: During a whole year, 6150 clinical samples were plated on CHROMagar Candida medium. After incubation, 
the green colonies were considered to be Candida albicans. The colonies of other colors were identified using 
Bichrolatex-krusei, or by their assimilation pattern on ID 32C test strips and their morphology on rice cream-agar-Tween. 
Results: Among the 6150 clinical samples, 1643 were positive for fungi. Aspergillus fumigatus and Geotrichum sp. 
were the predominant filamentous fungi isolated. Candida albicans was the most common species isolated (1274 of the 
positive samples; 77.5%), and Candida glabrata was the second most common yeast isolated (174 positive samples; 
10.6%). Other yeast species were detected at lower frequencies, mainly Candida tropicalis (3.8%), Candida krusei(2.7%), 
Saccharomyces cerevisiae (2.7%) and Candida kefyr (2.3%), and 16 samples revealed a lipophilic species, Malassezia 
furfur. Mixed fungal populations accounted for 14.7% of the positive samples. Two or more yeast species were detected 
in 206 of the 242 specimens containing mixed fungal populations, and five yeast species were detected in one sample. 
Additionally, we did not observe significant differences in the isolation of yeasts or filamentous fungi from the 366 
samples simultaneously plated on CHROMagar Candida and Sabouraud dextrose agar. Close agreement between the 
two culture media was observed for 89.9% of these samples. 
Conclusions: CHROMagar Candida medium was shown to be extremely helpful in a routine clinical mycology service, 
facilitating the detection of mixed cultures of yeasts and allowing direct identification of C. albicans, as well as rapid 
presumptive identification of the other yeasts: C. glabrata, C. tropicalis, C. krusei and S. cerevisiae. This chromogenic 
medium thus appears to be suitable as a primary culture medium, particularly for the mycologic surveillance of 
immunocompromised patients. 
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During the past two decades, the incidence of can- 
didiasis has increased markedly with the advent of 
new diseases such as the acquired immunodeficiency 
syndrome and the development of immunosuppressive 
therapy [1,2]. The increase in the length of hospitaliza- 
tion and in the severity of illness of hospitalized patients, 
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added to the widespread use of broad-spectrum anti- 
biotics and of invasive devices or procedures (e.g. 
parenteral hyperalimentation and placement of in- 
dwelling catheters), has also resulted in an increase in 
the rate of candidosis. Among the causative agents of 
these mycoses, Candida albicans is the most common 
species isolated, representing between 60% and 80% of 
all clinical isolates. However, recent data indicate a 
marked shift in the distribution of yeast species [2] .  
More than 30% of nosocomial infections are due to 
non-C. albicans species, such as C. glabrata, C. tropicalis 
and C. parapsilosis, which presently comprise with C. 
albicans nearly 95% of the clinical isolates of yeasts. For 
example, in the USA, the prevalence of C. albicans in 
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septicemia declined from 87% of the total yeast isolates 
in 1987 to a low of 31% in 1992 with concomitant 
increases of C. glabrata (from 2% to 26%), C. tropicalis 
(2% to 24%) and C. parapsilosis (9% to 20%) [3]. 
Furthermtire, other yeast species have emerged as 
pathogens in immunocompromised patients [2,4-61: 
C. krusei, C. lusitaniae, C. lipolytica and species belonging 
to the genus Trickosporon (T cutaneum) or Hansenula 
(H.  anomala). 
Isolation and prompt identification of the infecting 
microorganism are required for early antifungal therapy. 
Rapid presumptive identification of C. albicans has been 
based on the demonstration of germ tubes following 
incubation at 37 "C for 3 h in pooled human or animal 
serum [7]. However, this test, which is time- 
consuming, may lead to both false-positive and false- 
negative results [8-131. Full yeast identification by 
other current methods, such as the production of 
chlamydospores on rice cream-agar-Tween, and the 
ability to utilize sugars or to grow in the presence of 
cycloheximide, takes 48 to 72 h. 
Moreover, in addition to a dominant species, 
clinical samples may contain other associated yeast 
species which may come to dominate under selective 
pressure by an antifungal agent. Sabouraud dextrose 
agar (SDA) medium is widely used in medical 
mycology for the isolation and routine subculture of 
most common fungal pathogens [14]. However, precise 
identification of yeasts by colonial appearance on this 
culture medium is not possible in practice, and it is 
difficult to detect mixed cultures. Several primary 
culture media containing fluorogenic or chromogenic 
substrates specific for C. albicans have recently been 
developed. Among them, CHROMagar Candida is a 
new differential culture medium intended for the 
isolation and rapid presumptive identification of the 
most common clinically important yeast species. The 
basic performance of this culture medium has been 
extensively studied by Odds and Bernaerts [15] in an 
evaluation including 726 yeast isolates, of which most 
were collection strains. Its accuracy in clearly indicating 
colonies of C. albicans has recently been confirmed by 
different groups [16-191 using limited numbers of 
reference strains or of clinical isolates. This study was 
intended to assess the value of this culture medium in 
a very practical way in routine investigation of clinical 
specimens. 
MATERIALS AND METHODS 
Culture media 
CHROMagar Candida was supplied &om CHROMagar 
(Paris, France) as a dehydrated powder in preweighed 
batches for the preparation of 1000-mL volumes. The 
medium (which comprises, in grams per liter: peptone, 
10; glucose, 20; chromogenic mix, 2; chloramphenicol, 
0.5; agar, 15) was prepared according to the manu- 
facturer's instructions and dispensed into 95-mm- 
diameter Petri dishes (20 mL each). Plates were stored 
at 4°C and used within 2 weeks. SDA (containing in 
g per liter: peptone, 10; yeast extract, 5 ;  glucose, 20; 
chloramphenicol, 1; agar, 20) was prepared in our 
laboratory. 
Patients and clinical specimens 
This study involved 6150 clinical samples collected 
during a whole year and included the regular follow- 
up of patients and case studies of potential nosocomial 
infections by C. lusitaniae in a pediatric hospital 
department. The patients are classified into three 
groups: (1) HIV-positive patients, generally examined 
by mouth swabs (corresponding to 384 samples); (2) 
non-HIV immunocompromised patients from two 
hematology departments in Angers Hospital who were 
surveyed systematically each week for fungal risk by 
means of nostril, mouth and ear swabs, and by 
microbiological analysis of feces and urine, or patients 
hospitalized for pulmonary diseases and subjected to 
sputum or bronchoalveolar fluid analysis (329 1 
samples); and (3) non-immunocompromised patients 
displaying symptoms of bacterial or mycologic in- 
fection, or yeast allergy, and usually examined by 
vaginal swabs and further urine or feces analysis (2475 
samples). 
Study design 
Nostril, mouth, ear or vaginal swabs, as well as 100-pL 
aliquots for the urine samples, were plated on 
CHROMagar Candida medium (CHROMagar, Paris, 
France). Feces were suspended in 10 volumes of sterile 
distilled water, and 100-pL aliquots were streaked onto 
CHROMagar Candida. Likewise, 10-pL aliquots of 
sputum samples were directly applied on CHROMagar 
Candida plates, and simultaneously inoculated on SDA 
after pretreatment with an equal volume of a muco- 
lytic agent (Digest-EUR; Eurobio, Les Ulis, France). 
Centrifugation pellets of bronchoalveolar fluids and 
homogenized biopsies were cultured simultaneously on 
SDA and CHROMagar Candida plates. After inocula- 
tion, the plates were incubated at 37 "C and examined 
daily for 7 days. 
Filamentous fungi were identified on the basis of 
their macroscopic and microscopic morphology. Among 
yeast isolates, the green colonies on CHROMagar 
Candida were considered to be C. albicans on the basis 
of the manufacturer's instructions and previous reports 
[15-191. Colonies on SDA were identified as C. albicans 
using Bichrolatex albicans (Laboratoires Fumouze, 
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Table 1 Mixed populations of fungi detected on 
CHROMagar Candida medmm in the three patient groups 
Number of samples 
containing several 
(ti) associated fungi Positive cultures 
(total number 
Study patient group ofsamples) n=2 n = 3  n = 4  n=5 
HIV patients 219 (384) 30 2 
Non-HIV immuno- 
compromised patients 450 (3291) 48 4 
Non-immuno- 
compromised patients 974 (2475) 142 13 2 1 
Total 1643 (6150) 220 19 2 1 
Asnihes, France). Colonies of other colors from 
CHROMagar Candida and non-C. albicans yeast 
isolates from SDA were identified using Bichrolatex- 
krusei [20] or by their auxanographic characters on ID 
32C test strips (bioMkrieux, Marcy-l’Etoile, France) 
and their morphology on rice cream-agar-Tween. 
During the experimental period, 61 50 clinical samples 
were examined and, of these, 1643 (26.7%) contained 
fungi. A total of 118 filamentous fungi and of 1793 
yeast isolates was recovered. Mixed populations of fungi 
accounted for 14.7% of the positive samples (Table 1). 
Two different species associated were recovered from 
220 samples: two filamentous fungi in one sample, a 
yeast and a filamentous fungus in 35 samples, and two 
yeast species in 184 samples. Among the samples 
containing three different species, yeasts were associated 
with a filamentous fungus in four cases, and three yeast 
species were recovered in 15 specimens. Three yeast 
species associated with a filamentous fungus were 
recovered from two samples, and one sample contained 
five associated yeast species. 
Our study permitted a detailed description of the 
different parts of the body from which fungi could be 
isolated and allowed us to refine this analysis species by 
species. The isolated filamentous fungi are presented in 
Table 2, and the yeasts in Table 3. The dominant species 
were C. albicans and C. glabrata, which accounted for 
77.5% and 10.6% of the positive specimens, respec- 
tively. Other yeast species were detected at lower 
frequencies, mainly C. tropicalis (3.8%), C. krusei (2.7%), 
Saccharomyces cerevisiae (2.7%) and C. kefvr (2.3%). 
Surprisingly, 16 samples plated on CHROMagar 
Candida, a medium which does not contain lipids, 
revealed very small colonies of yeasts that we identified 
as Malassezia fu$ur, a lipophilic species. These isolates, 
which could not be subcultured and did not grow on 
ID 32C test strips, were identified on the basis of the 
colony morphology on primary plates, in addition to 
microscopic examination and colony development after 
addition of olive oil to the surface of the culture 
medium. 
As shown in Table 4, mixed species of fungi were 
recovered from various specimens, with a relatively 
high frequency in pulmonary specimens (26.7% of the 
positive samples), and, in contrast very low frequency 
in genital specimens (3.8%), in which a single species, 
either C. albicans (86.3%) or C. glabrata (7.7%), was 
commonly isolated. The most common associations are 
summarized in Table 4. C. albicans was detected in 
77.8% of the samples containing two yeast species. In 
addition, at least three different yeast species were 
simultaneously recovered from 18 specimens, and C. 
albicans and C. glabrata were recovered in association 
with another species in four of these samples. Of all 
specimens containing mixed fungal populations, C. 
albicans was detected in 79.3%, and C. glabrata in 35.5%, 
and at least two non-C. albicans yeast species were 
recovered from 9.5%. Filamentous fungi were 
recovered in association with yeasts from 41 out of 1643 
Table 2 Filamentous hngi detected using CHROMagar Candida medium 
Specimens Total 
number of 
Nostril Ear Buccal Pulmonary Digestive Genital Urine Cutaneous Other positive 
Fungal species ( ~ ~ ~ 7 0 9 )  (rr=384) (n=1929) (n=344) (ri=1009) (n=834) (n=702) (n=127) (n=112) samples 
Absidia sp. 1 1 
Aspe yillus fim igatus 7 1 4 40 2 1 55 
Aspeyillus Javus 1 4 5 
Asper$lus terreus 1 1 
Fnsariurn sp. 1 1 
Geotriclitrrn sp. 5 1 47 1 54 
Eirlmopl~ytoit mentqwpliytrs 1 1 
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Table 3 Yeast species detected using CHROMagar Candida memuin 
Specimens Totdl number 
of 
Nostril Ear Buccal Pulmonary Lligestive Genital Urine Cutaneous Other positive 
Fungal species (r1=709) (n=384) (rt=1929) (n=344) (rr=l009) (r1=834) (rr=702) (rr=127) ( t i =  112) samples 
Candida albirarrs 3 1 607 118 235 211 37 47 15 1274 
Candida glabrata 2 57 14 43 23 27 5 3 174 
Candida ~qtiilliermorrdii 5 3 4 2 14 
Caridida liolmii 1 1 
Carrdida lrtrmiiola 1 1 
Candida kefrr 12 1 22 2 38 
Caridida krnsei 25 4 12 3 45 
Candida lambica 2 - 3
Carrdida lipolytica 1 1 
Caridida lirsitariiae 11 1 15 1 2 3 6 
Candida riorvegensis 2 1 3 
Candida parapsilosis 2 1 7 5 7 1 1 24 
Candida pellirulosa 4 1 5 
Caitdida r n p a  7 4 11 
Caridida sphaerica I 2 
Crypfocorciis weoformaris 2 2 
Malassrzia 6rrf.r 7 8 16 
Malaszrzia paiiiydrrriiaris 1 1 
Pirlria sp. 1 1 2 
Saccliaromyies cerevisiae I 1  3 25 2 2 1 44 
Tricliosporow capitarum 2 1 3 
Trirhosporow infanerim 1 2 3 
Candida irrcorispicua 12 1 6 I 20 
3 
Candtda tropicalis 28 15 14 2 62 






Zypsacrharomyies sp. 4 4 8 
positive samples. However, the majority of the mixed 
populations contained only yeasts, and, for instance, 
the sample with five different species contained five 
Candida species which could be differentiated on 
CHROMagar Candida (C. albicans, C. tropicalis, C. 
kefyr, C. inconspicua and C. luritaniae). 
Additionally, there were no significant differences 
in the isolation of yeasts or filamentous fungi for 
the 366 clinical samples simultaneously plated on 
CHROMagar Candida and SDA. Overall agreement 
between the two culture media was 89.9%: 189 samples 
were negative on both media, and among the samples 
Table 4 Main associations of fungi detected using CHROMagar Candida medium 
Specimens Total nutiiber 
of positive 
Nostril Edr Buccal Pulmonary Digestive Genital Urine Cutdneous Other samples 
POSltlVe SdmpkS 20 10 704 161 359 234 76 50 29 1643 
Samples containing 
mixed fungal populations 1 1 93 43 7 9 9 4 9 3 242 
Main associations detected,' 
C. albicans + S. iereuisiae 7 1 8 2 18 
C. albicans + C. krurei 11 3 2 16 
C. albiians + A .  fnm<qatus 16 16 
C. albiians + C. 'qlabrara 29 6 24 5 4 5 73 
C. alhiians + C. tropicalis 7 1 3 1 3 15 
C. albiims + Ceufriihtim sp. 2 9 1 12 
C. albiiatis + C. k@yr I 5 1 7 
C. albiiarrs + C. inionspicua 4 1 I 6 
'Detected in more than five samples. 
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Table 5 Differences in the species detected between 
CHROMagar Candda and SDA plates 
Number of 
CHROMagar Candida SDA positive cultures 
~~ ~ 
None Alrernaria sp. 1 4  
None M u m  sp. 1“ 
None Penin’llinm sp. 1 
None Rliizopns sp. 1 4  
None C. &brafa 1.‘ 
A .  fumtgatus None 3‘ 
A .  j’lauus None 1 
C. xlabrata None 1 
c. kefyr None I 
A. frrmigafus + C. albicans A. fumigafus 2 
A .  filmi,qafus + C. albicans C. albicans 3 
C. albicans A. fumigatus 2 
None C. albicans Sh 
C. albicans None 5 
A. furnipatus A.  fumigatus + 
C. albicans 1 
C. albicans A .  -fnmipfus + 
C. albicans Cladosporiuni sp. + 
C. albicans 3 
C. albicans 1 
A. fum&afus  + C. tropicalis C. tropicalis 1 
A. j’lauus + C. albicans C. albicans 1 
A. j ’ la ims + C. tropicalis C. tropicalis 1 
Only one colony detected. 
Only one to five colonies for four of the samples. 
Only one colony for one of the samples. 
positive on CHROMagar Candida and/or SDA, 140 
gave identical results on the two media. Table 5 
shows the differences in the species detected between 
CHROMagar and SDA plates. 
DISCUSSION 
The presence of more than one yeast species in clinical 
samples is not uncommon. Yamane and Saitoh [21] as 
well as Samaranayake et al. [22] have reported the 
association of yeast species with a relatively high 
fiequency, ranging from 8% to 15.3% of the positive 
cultures, varying with the nature of the samples. The 
prompt detection of associated yeast species and 
presumptive identification of the isolated yeasts may be 
an aid for rapid appropriate treatment decisions, in the 
light of differences in susceptibility of the yeast species 
to antibngal agents [23]. Some Candida species such as 
C. lusitaniae are often resistant to amphotericin B; 
numerous isolates of C. tropicaliz are resistant to 5- 
fluorocytosine; C. glabrata is less sensitive than other 
species to ketoconazole and fluconazole; and C. krusei 
exhibits innate resistance to fluconazole. Thus, there 
has been increasing concern during the past few years 
that the extended use of ketoconazole or fluconazole as 
prophylactic or curative agents for mycoses may be 
associated with an increased incidence of C. glabrata and 
C. krusei infections. 
According to Yamane and Saitoh [21], only 26% 
of mixed populations of yeasts are detected on 
SDA. Differential culture media have therefore been 
developed, based on a varying pigmentation of the 
colonies by reduction of an inorganic substrate added 
to the medium, such as phosphomolybdate [24,25], 
2,3,5-triphenyltetrazolium chloride in Pagano-Levin’s 
culture medium [26] or bismuth polysulphite in 
Nickerson’s medium [27]. Likewise, the YM + aniline 
blue dye medium enables the direct identification of C. 
albicans which, on this medium, specifically forms a 
fluorescent metabolite that can be visualized with long- 
wave W light [28]. However, the phosphomolybdate 
agar medium is not commercially available, and the 
limited color variations of the colonies on the other 
media (fiom brown to black on bismuth-based media, 
and fi-om white to pink on Pagan-Levin’s medium, 
depending on the species) may lead to an incorrect 
evaluation of the real number of associated species 
[29-321. A reduction in the number of colonies and in 
their size has often been reported on Pagano-Levin’s 
medium compared with the results on SDA. Moreover 
the growth of some yeast species such as C.  fusitaniae, 
C. lambica and Cryptococcus albidus appears to be partly 
inhibited on this culture medium. 
More recently, differential culture media based on 
the detection of the N-acetyl-P-D-galactosaminidase 
specific to C. atbicans have been proposed: Fluoroplate 
Candida agar fi-om Merck, CANDICHROM albicans 
from International Mycoplasma, Albicans ID fi-om 
bioMCrieux and CandiSelect fiom Diagnostics Pasteur 
[19,33-351. With fluoroplate Candida agar, which 
requires the use of a W lamp for interpretation, a 
diffusion of the fluorescent product to neighboring 
colonies is often observed after 48 h of incubation, 
which may lead to misidentification of non-C. albicans- 
associated yeasts [35]. Additionally, all these culture 
media differentiate only the colonies of C. albicans from 
the non-fluorescent or colorless colonies of non- 
C. albicans yeast species. With CHROMagar Canhda 
medium, there was no delay in yeast detection and no 
change in the size of colonies compared with that 
obtained on SDA when the same clinical samples 
were plated onto the two culture media. Likewise, 
we did not observe significant differences between 
CHROMagar Candida and SDA with regard to the 
growth of filamentous fungi, thus confirming the 
observations of Odds and Bernaerts [15] using 
reference strains of dermatophytes and moulds, 
including some asperg&. 
B o u c h a r a  e t  a l :  R o u t i n e  u s e  o f  C H R O M a g a r  C a n d i d a  m e d i u m  207 
Like the other chromogenic media, CHROMagar 
Candida allows the direct identification of C. albicans, 
characterized by the green color and the smooth aspect 
of the colonies. Moreover, this medium allows the 
presumptive identification of additional species such as 
C. tropicalzs (metallic blue colonies), S. cereuisiae (purple 
colonies with a dark halo in agar) and C. glabrata (white 
or purple, smooth, glittering colonies). C. krusei is also 
easily recognizable by its pale rose, flat and spreading 
colonies with a broad white fringe, and its identi- 
fication is rapidly confirmed by using Bichrolatex- 
krusei [20]. In our hands, CHROMagar Candida 
correctly identified 100% of C. krusei isolates, and 
the presumptively identified C. tropicalis isolates were 
always confirmed by conventional methods. However, 
on the basis of colony morphology and pigmentation 
on CHROMagar, 8.5% of C. tropicalis isolates were 
misidentified as S. cerevisiae. In addition, this culture 
medium also permitted the detection of M.  f u f u r ,  a 
yeast known for its requirement for lipids. Isolation of 
this yeast, which usually grows on the sebaceous parts 
of the skin, may be surprising. However, its presence 
in ear and nostril specimens, but also in urine samples 
of patients undergoing parenteral hyperalimentation, is 
not uncommon. Our isolates were obtained from four 
young patients hospitalized in a pediatric hematology 
department of Angers hospital for cancer or hemato- 
logic malignancies. One of them presented a positive 
urine sample. Another isolate was obtained from an 
ear specimen in a second patient, associated with C. 
parapsilosis. A third patient presented five positive nostril 
swabs, and the nine other isolates were from a single 
patient. 
With a frequency of 14.7% of the positive samples, 
our study confirms the previous observations of the 
fkequency of mixed fungal populations [17,21,22]. For 
example, in the study of Pfaller et al. [17], 18% of the 
positive samples contained mixtures of yeast species, 
and 20% of these mixed cultures were not detected on 
SDA. All our samples were not inoculated in parallel on 
SDA. It seems, however, that the use of CHROMagar 
Candida greatly increases the percentage of mixed 
fungal populations detected in clinical samples, since, 
until the introduction of this chromogenic medlum in 
our hospital laboratory, their frequency was obviously 
much lower (5.4% in 1993). 
As has previously been observed with the use 
of Pagano-Levin’s culture medium [21,22] or 
CHROMagar Candida [17], the most common 
association was C. albicans + C. glabrata, which was 
detected in 30% of the samples containing mixed fungal 
populations (46.5% according to Pfaller et al. [17]). 
However, quite a number of samples contained at 
least two non-C. albicans-associated yeasts. For example, 
during the course of our routine systematic work, the 
following investigation was carried out. After several 
isolates of C. lusitaniae had been obtained from children 
in a pedatric hematology department, 60 members of 
the personnel of this hospital unit were investigated by 
mouth swab, urine and feces analysis for asymptomatic 
carriage of this rather rare species. In only one case was 
C. lusitaniae isolated in a mixed population including 
four other species: C. albicans, C. tropicalis, C. kefrr and 
C. inconspicua. Obviously, such detailed study with 
naturally occurring mixed populations would have been 
very difficult, if at  all possible, without CHROMagar 
Candida, which is a powerful tool for the differen- 
tiation of yeast species. 
In conclusion, in spite of its greater cost (in 
comparison with SDA), CHROMagar Candida medium 
was found to be extremely helpful, allowing direct 
identification of C. albicans colonies as well as the 
presumptive identification of the other most common 
yeasts, and the easy recognition of associations of 
multiple yeast species. Thus this easy-to-use and time- 
saving medium appears to be well suited for routine use 
in clinical mycology laboratories. 
References 
1. Jarvis WR.  Epidemiology of nosocomial fungal infections, 
with emphasis on Candida species. Clin Infect Dis 1995; 20: 
1526-30. 
2. Wingard JR. Importance of Candida species other than C. 
albicans as pathogens in oncology patients. Clin Infect Dis 
3. Price MF, LaRocco MT, Gentry LO. Fluconazole suscep- 
tibilities of Candida species and distribution of species 
recovered &om blood cultures over a 5-year period. Anti- 
microb Agents Chemother 1994; 38: 1422-4. 
4. Anaissie E, Bodey GF’, Kantajian H, et al. New spectrum of 
fungal infections in patients with cancer. Rev Infect Dis 
5. Goss G, Grigg A, Rathbone J?, Slavin M. Hansenula anomala 
infection after bone marrow transplantation. Bone Marrow 
Transplant 1994; 14: 995-7. 
4. Samaranayake YH, Samaranayake LP Candida krusei: biology, 
epidemiology, pathogenicity and clinical manifestations of an 
emerging pathogen. J Med Microbiol 1994; 41: 295-310. 
7. Taschdjian CL, Burchall JJ, Kozinn PJ. Rapid identification 
of Candida albicans by fdamentation on serum and serum 
substitutes. Am] Dis Child 1960; 99: 212-15. 
8. Martin MV Germ-tube formation by oral strains of Curididu 
tropicalis. J Med Microbiol 1979; 12: 187-93. 
9. Fell JW, Meyer SA. Systematics of yeast species in the 
Candida parapsilosis group. Mycopathol Mycol Appl 1947; 
10. Huppert M, Harper G, Sun SH, Delanerolle V. Rapid 
methods for identification of yeasts. J Clin Microbiol 1975; 
1995; 20: 115-25. 
1989; I 1: 349-78. 
32: 177-93. 
2: 21-34. 
208 C l i n i c a l  M i c r o b i o l o g y  a n d  I n f e c t i o n ,  Vo lume 2 N u m b e r  3 ,  D e c e m b e r  1996 
11. Katsura Y, Uesaka I. Assessment of germ tube dlspersion 
activity of serum from experimental candidiasis: a new 
procedure for serodiagnosis. Infect Immun 1974; 9: 788-93. 
12. Landau JW, Dabrowa N, Newcomer VD. The rapid forma- 
tion ofserum filaments by Candida albicans. J Invest Dermatol 
13. Salkin IF, Land GA, Hurd NJ, Goldson PR,  MacGinnis MR.  
Evaluation of YeastIdent and Uni-Yeast-Tek yeast identifica- 
tion systems. J Clin Microbiol 1987; 25: 624-47. 
14. Odds FC. Sabouraud('s) agar. J Med Vet Mycol 1991; 29: 
355-9. 
15. Odds FC, Bernaerts R. CHROMagar Candida, a new 
dlfferential isolation medium for presumptive identification 
of clinically important Candida species. J Clin Microbiol 
16. Beighton D, Ludford R, Clark DT, et al. Use of 
CHROMagar Candida mehum for isolation of yeasts from 
dental samples. J Clin Microbiol 1995; 33: 3025-7. 
17. Pfaller MA, Houston A, Coffhan S. Application of 
CHROMagar Candida for rapid screening of clinical 
specimens for Candida albicans, Candida tropicalis, Candida 
krusei, and Candida (Tomlopsis) glabrata. J Clin Microbiol 
18. San-Millan R, Rtbacoba L, Ponton J, Quindos G. 
Evaluation of a commercial medium for identification of 
Candida species. Eur J Clin Microbiol Infect Dis 1996; 15: 
19. Baumgartner C, Freydkre AM, Gille Y. Direct identification 
and recognition of yeast species from clinical material by 
using Albicans ID and CHROMagar CanAda plates. J Clin 
Microbiol 1996; 34: 454-6. 
20. Robert R, Bernard C, Senet JM. Rapid identification of 
Candida krusei. In Program and Abstracts of the 1st Congress 
of the European Confederation of Medical Mycology, 
Institut Pasteur, Paris, France. Paris: Institut Pasteur, 1993: 18. 
21. Yamane N, Saitoh Y. Isolation and detection of multiple 
yeasts from a single clinical sample by use of Pagano-Levin 
agar medium. J Clin Microbiol 1985; 21: 276-7. 
22. Samaranayake LP, MacFarlane TW, Wdliamson MI. 
Comparison of Sabouraud dextrose and Pagano-Levin agar 
media for detection and isolation of yeasts &om oral samples. 
J Clin Microbiol 1987; 25: 162-4. 
1965; 44: 171-9. 
1994; 32: 1923-9. 
1996; 34: 58-61. 
153-8. 
23. DeMuri GP, Hostetter MK. Resistance to antifungal agents. 
Pedlatr Clin North Am 1995; 42: 665-85. 
24. Costa SOP, de Lourdes Branco C. Evaluation of a molyb- 
denum culture medlum as selective and Afferential for yeasts. 
J Pathol Bacteriol 1964; 87: 428-31. 
25. Bump CM, Kunz LJ. Routine identification of yeasts with 
the aid of molybdate-agar medlum. Appl Microbiol 1968; 
16: 1503-6. 
26. Pagano J, Levin JD, Trejo W. Diagnostic medlum for 
differentiation of species of Candida. Antibiot Annu 1958; 
27. Nickerson WJ. Reduction of inorganic substances by yeasts. 
I. Extracellular reduction of sulfite by species of Candida. 
J Infect Dis 1953; 93: 43-56. 
28. Goldschmidt MC, Fung DYC, Grant R, White J, Brown T. 
New aniline blue dye medlum for rapid identification and 
isolation of Candida albicans. J Clin Microbiol 1991; 29: 
29. Mendel EB, Haberman S, Hall DK. Isolation of Candida 
from clinical specimens. Comparative study of Pagano-Levin 
and Nickerson's culture meha. Obstet Gynecol 1960; 16: 
180-4. 
30. Sinsh JT. The effectiveness ofPagano-Levin medlum for the 
detection and identification of Candida albicans in clinical 
specimens. J Invest Dermatol 1960; 35: 131-3. 
31. Sinslu JT, Kelley LM, Reed GL. Pagano-Levin Candida test 
medlum: evaluation using vaginal samples. J Clin Microbiol 
1975; 1: 206-11. 
32. Schnell JD. Investigations into the pathoaetiology and diag- 
nosis of vaginal mycoses. Chemotherapy 1982; 28 (suppl 1): 
33. Manafi M,  Wdlinger B. Rapid identification of Candida 
albicans by fluoroplate Candida agar. J Microbiol Meth 1991; 
34. Lipperheide V, Andraka L, Ponton J, Quindos G. Evaluation 
of the Albicans ID" plate method for the rapid identification 
of Candida albicans. Mycoses 1993; 36: 417-20. 
35. Rousselle P, Freydlere AM, Coudlerot PJ, de Montclos H,  
Gille Y. Rapid identification of Candida albicans by using 
Albicans ID and Fluoroplate agar plates. J Clin Microbiol 
1994; 32: 3034-6. 
1957-1 958: 137-43. 
1095-9. 
14-21. 
14: 103-7. 
